NASDAQ:GLUE

Monte Rosa Therapeutics Stock Insider Trading

etoro logo Buy GLUE
*Your capital is at risk
$23.04
-1.48 (-6.04%)
At Close: Jul 10, 2026

Monte Rosa Therapeutics Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -23.77. In total, the insiders bought 1.8M and sold 1.21M GLUE shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
-23.77
Buy 1.8M shares
Sell 1.21M shares
64% Buy Activity
Moderate Positive Correlation
Sell Signal Medium Confidence
Jul 01, 2026

Analysis Breakdown:

  • Supported by a negative Insider Power Score of -23.77.
  • Partially supported by a positive historical correlation.
  • Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date Type Person Role Amount
Jul 06, 2026
Sell
Common Stock
S-Sale
Townson Sharon
Chief Scientific Officer
Officer 400
Value: $10K
Jul 06, 2026
Sell
Common Stock
S-Sale
Townson Sharon
Chief Scientific Officer
Officer 5 600
Value: $130.2K
Jul 06, 2026
Buy
Common Stock
M-Exempt
Townson Sharon
Chief Scientific Officer
Officer 6 000
Value: $36.8K
Jul 06, 2026
Buy
Stock Option (Right to Buy)
M-Exempt
Townson Sharon
Chief Scientific Officer
Officer 6 000
Value: $36.8K
Jul 01, 2026
Sell
Common Stock
J-Other
Behbahani Ali
Director
Director 15 000
Value: $0
Jul 01, 2026
Buy
Common Stock
J-Other
Behbahani Ali
Director
Director 15 000
Value: $360.3K
Jul 01, 2026
Sell
Common Stock
J-Other
Behbahani Ali
Director
Director 1 000 000
Value: $0
Jun 30, 2026
Buy
Stock Option (Right to Buy)
M-Exempt
Janku Filip
Chief Medical Officer
Officer 5 407
Value: $72.5K
Jun 30, 2026
Buy
Common Stock
M-Exempt
Janku Filip
Chief Medical Officer
Officer 5 407
Value: $72.5K
Jun 30, 2026
Sell
Common Stock
S-Sale
Janku Filip
Chief Medical Officer
Officer 5 407
Value: $132.5K
Jun 29, 2026
Buy
Stock Option (Right to Buy)
M-Exempt
Manning Anthony M.
Director
Director 10 000
Value: $41.6K
Jun 29, 2026
Sell
Common Stock
S-Sale
Janku Filip
Chief Medical Officer
Officer 6 000
Value: $137.7K
Jun 29, 2026
Buy
Common Stock
M-Exempt
Janku Filip
Chief Medical Officer
Officer 6 000
Value: $45.4K
Jun 29, 2026
Buy
Stock Option (Right to Buy)
M-Exempt
Janku Filip
Chief Medical Officer
Officer 6 000
Value: $45.4K
Jun 29, 2026
Buy
Common Stock
M-Exempt
Manning Anthony M.
Director
Director 10 000
Value: $41.6K
Jun 29, 2026
Sell
Common Stock
S-Sale
Manning Anthony M.
Director
Director 10 000
Value: $231.1K
Jun 24, 2026
Buy
Common Stock
M-Exempt
Janku Filip
Chief Medical Officer
Officer 30 000
Value: $226.8K
Jun 24, 2026
Buy
Stock Option (Right to Buy)
M-Exempt
Janku Filip
Chief Medical Officer
Officer 30 000
Value: $226.8K
Jun 24, 2026
Sell
Common Stock
S-Sale
Janku Filip
Chief Medical Officer
Officer 30 000
Value: $642.7K
Jun 23, 2026
Buy
Stock Option (Right to Buy)
M-Exempt
Janku Filip
Chief Medical Officer
Officer 6 000
Value: $45.4K
Jun 23, 2026
Buy
Common Stock
M-Exempt
Janku Filip
Chief Medical Officer
Officer 6 000
Value: $45.4K
Jun 23, 2026
Sell
Common Stock
S-Sale
Janku Filip
Chief Medical Officer
Officer 11 845
Value: $239.5K
Jun 23, 2026
Buy
Common Stock
M-Exempt
Champoux Jennifer
Chief Operating Officer
C-Suite Officer 2 175
Value: $9K
Jun 23, 2026
Sell
Common Stock
S-Sale
Champoux Jennifer
Chief Operating Officer
C-Suite Officer 2 175
Value: $43.5K
Jun 23, 2026
Buy
Stock Option (Right to Buy)
M-Exempt
Champoux Jennifer
Chief Operating Officer
C-Suite Officer 2 175
Value: $9K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT MONTE ROSA THERAPEUTICS, INC.
Monte Rosa Therapeutics
Monte Rosa Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel small molecule precision medicines that employ the body's natural mechanisms to selectively degrade therapeutically relevant proteins. It develops an oral molecular glue degrader for GSPT1, a translational termination factor and degron-containing protein for the treatment of Myc-driven cancers. The company also develops CDK2 to treat ovarian, uterine, ...
GOLDEN STAR
Ticker Change Signal Date
SRPT
$17.02
11.34% Jun 29
NMRK
$15.02
1.20% Jun 24
NESR
$25.07
14.16% Jun 23
CAG
$13.43
2.98% Jun 23
GIB
$66.69
0.555% Jun 12

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE